New Model Can Predict Cellular Drug Targets Against COVID-19
University of Warwick | November27th,2020
Drugs could potentially target host-based metabolic perturbations to inhibit SARS-CoV-2 reproduction
Coronavirus
Mammoth Biosciences Signs Agreements with MilliporeSigma and Hamilton Company Targeting Commercialization of High-Throughput CRISPR-based SARS CoV-2 Test
Mammoth Biosciences | November26th,2020
The company has signed agreements with MilliporeSigma to scale manufacturing and with Hamilton Company to market a turnkey solution to help CLIA laboratories rapidly add testing capacity
Researchers Reveal How Genetic Variations Are Linked to COVID-19 Severity
Beth Israel Deaconess Medical Center | November26th,2020
Genomic "hot spots" associated with COVID-19 severity could be targets for therapeutic intervention
COVID-19 Virus Survives on Surfaces for Hours
American Institute of Physics | November25th,2020
Researchers found that the SARS-CoV-2 virus survived on surfaces for hours within a thin film
Heparan Sulfate Products for COVID-19 Infection, Disease, & Therapeutics Research
AMSBIO | November24th,2020
Heparan sulfate is increasingly recognized as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 coronavirus pandemic
Latest Data Shows Oxford's COVID-19 Vaccine Is 70.4 Percent Effective
Miriam Bergeret, MSc | November24th,2020
The results are based on two dosing schedules, one of which is 90 percent effective
AI Detects COVID-19 on Chest X-Rays With Accuracy and Speed
Northwestern University | November24th,2020
The largest published clinical dataset of chest X-rays from COVID-19 patients was used to train the AI system
Researchers Identify Three Possible Therapeutics for COVID-19
University of Tennessee | November23rd,2020
The researchers examined 4,000 approved drugs and found three that act similarly to the hydroxychloroquine
Phase 2 Trial of Oxford COVID-19 Vaccine in Older Adults Finds It Is Safe
The Lancet | November20th,2020
Robust antibody and T-cell response seen in older adults is encouraging
Early Analysis Finds Moderna's COVID-19 Vaccine Is 94.5 Percent Effective
Miriam Bergeret, MSc | November19th,2020
The vaccine trial reports 95 confirmed cases of COVID-19 with only 5 in the vaccinated group—a statistically significant result